Improvement of taste perception by homoeriodictyol in cancer patients after chemotherapy
Dauer: 60 Monate, Fördersumme: € 362.540
Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine
Dauer: 60 Monate, Fördersumme: € 799.350
Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy
Dauer: 48 Monate, Fördersumme: € 799.510